ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $512,000 | -95.8% | 9,569 | -96.2% | 0.01% | -93.9% |
| Q2 2020 | $12,219,000 | +2522.1% | 252,100 | +2216.5% | 0.21% | +2928.6% |
| Q4 2019 | $466,000 | -32.1% | 10,883 | -57.6% | 0.01% | -41.7% |
| Q2 2019 | $686,000 | -39.9% | 25,673 | -39.6% | 0.01% | -57.1% |
| Q1 2019 | $1,142,000 | +150.4% | 42,527 | +50.9% | 0.03% | +100.0% |
| Q4 2018 | $456,000 | -33.5% | 28,188 | +54.9% | 0.01% | +55.6% |
| Q3 2017 | $686,000 | -5.5% | 18,200 | -13.8% | 0.01% | 0.0% |
| Q1 2017 | $726,000 | -20.3% | 21,125 | -26.2% | 0.01% | -18.2% |
| Q3 2016 | $911,000 | -79.9% | 28,636 | -79.5% | 0.01% | -78.0% |
| Q2 2016 | $4,524,000 | +1875.5% | 139,382 | +2061.3% | 0.05% | +733.3% |
| Q4 2015 | $229,000 | -26.1% | 6,449 | -12.9% | 0.01% | 0.0% |
| Q2 2015 | $310,000 | +7.6% | 7,400 | -36.5% | 0.01% | -53.8% |
| Q3 2014 | $288,000 | -47.6% | 11,650 | -52.1% | 0.01% | -43.5% |
| Q2 2014 | $550,000 | – | 24,329 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |